🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › California › Sacramento

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Sacramento, CA keessatti

Qorannoo 12 Leukemia Myeloidii Hamaa f Sacramento fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Kaiser Permanente Downtown Commons, Sacramento
  • University of California Davis Comprehensive Cancer Center, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent

Namoota walitti qabaa jiraSadarkaa 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07304011

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · Miili 16 fagaatti
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • UC Davis, Sacramento
Umuriin 12 hanga 78 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT03802695

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Kaiser Permanente Downtown Commons, Sacramento
  • University of California Davis Comprehensive Cancer Center, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • University of California Davis Comprehensive Cancer Center, Sacramento
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

Namoota walitti qabaa jiraSadarkaa 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06834282

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Sutter Medical Center, Sacramento
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Namoota walitti qabaa jiraSadarkaa 2
  • University of California Davis Health (UC Davis Health), Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Ama-2026 · NCT05184842

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of California, Davis, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2025 · NCT03850574

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

Namoota walitti qabaa jiraSadarkaa 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Cam-2024 · NCT04905810

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Sacramento keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.